CLINICAL_TRIALS
trial_result
· 2017-03-07
Clinical Trial Update: Long-term Safety Study of Intramuscular Injections of 750 mg and 1000 mg Testosterone Undecanoate in Hypogonadal Men [Phase 3]
Summary
Phase 3 long-term safety study of intramuscular testosterone undecanoate in hypogonadal men has completed; results posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Endo Pharmaceuticals | Conditions: Hypogonadism, Primary Hypogonadism | Phase 3 | Status: COMPLETED | Results posted: 2017-03-07